tiprankstipranks
Advertisement
Advertisement

OTLK Stock Latest News

Outlook Therapeutics Regains Nasdaq Minimum Bid Compliance
Company AnnouncementsOutlook Therapeutics Regains Nasdaq Minimum Bid Compliance
10d ago
8K
OTLK
Outlook Therapeutics’ Resubmitted ONS-5010 BLA Accepted by FDA
PremiumCompany Announcements
Outlook Therapeutics’ Resubmitted ONS-5010 BLA Accepted by FDA
20d ago
8K
OTLK
Outlook Therapeutics resubmits ONS-5010 biologics license application to FDA
PremiumThe Fly
Outlook Therapeutics resubmits ONS-5010 biologics license application to FDA
20d ago
OTLK
Outlook Therapeutics Resubmits FDA Application for ONS-5010
PremiumCompany Announcements
Outlook Therapeutics Resubmits FDA Application for ONS-5010
1M ago
8K
OTLK
Outlook Therapeutics resubmits biologics license application to FDA
PremiumThe Fly
Outlook Therapeutics resubmits biologics license application to FDA
1M ago
OTLK
Outlook Therapeutics Announces Registered Direct Equity Offering
PremiumCompany AnnouncementsOutlook Therapeutics Announces Registered Direct Equity Offering
1M ago
8K
OTLK
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
NFE
YSS
Outlook Therapeutics Announces Insider-Backed Direct Stock Offering
Premium
Company Announcements
Outlook Therapeutics Announces Insider-Backed Direct Stock Offering
1M ago
8K
OTLK
Outlook Therapeutics announces pricing of $5M registered direct offering
PremiumThe Fly
Outlook Therapeutics announces pricing of $5M registered direct offering
1M ago
OTLK
Outlook to sell 8.54M shares at 58.55c in registered direct offering
PremiumThe Fly
Outlook to sell 8.54M shares at 58.55c in registered direct offering
1M ago
OTLK
Outlook Therapeutics wins appeal following FDR process for ONS-5010/Lytenava
PremiumThe Fly
Outlook Therapeutics wins appeal following FDR process for ONS-5010/Lytenava
1M ago
OTLK
Outlook Therapeutics Wins FDA Appeal for LYTENAVA Resubmission
PremiumCompany Announcements
Outlook Therapeutics Wins FDA Appeal for LYTENAVA Resubmission
1M ago
8K
OTLK
Outlook Therapeutics downgraded to Neutral from Buy at BTIG
PremiumThe FlyOutlook Therapeutics downgraded to Neutral from Buy at BTIG
2M ago
OTLK
Outlook Therapeutics reports Q2 adjusted EPS (16c), consensus (12c)
Premium
The Fly
Outlook Therapeutics reports Q2 adjusted EPS (16c), consensus (12c)
2M ago
OTLK
Outlook Therapeutics Launches New $100M ATM Offering
Premium
Company Announcements
Outlook Therapeutics Launches New $100M ATM Offering
2M ago
8K
OTLK
OTLK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
OTLK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
OTLK
Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/11/26?
PremiumMarket News
Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/11/26?
2M ago
MXL
RXT
Outlook Therapeutics Announces New Equity Financing Transaction
PremiumCompany Announcements
Outlook Therapeutics Announces New Equity Financing Transaction
2M ago
8K
OTLK
Outlook Therapeutics to sell 16.129M shares at 31c in registered direct offering
PremiumThe Fly
Outlook Therapeutics to sell 16.129M shares at 31c in registered direct offering
3M ago
OTLK
Outlook Therapeutics Advances FDA Dispute on Wet AMD Drug
PremiumCompany AnnouncementsOutlook Therapeutics Advances FDA Dispute on Wet AMD Drug
3M ago
8K
OTLK
Outlook Therapeutics completes Federal Dispute Resolution meeting with FDA
Premium
The Fly
Outlook Therapeutics completes Federal Dispute Resolution meeting with FDA
3M ago
OTLK
Regulatory Uncertainty and Data Limitations Justify Hold Rating and Constrained Upside for Outlook Therapeutics
Premium
Ratings
Regulatory Uncertainty and Data Limitations Justify Hold Rating and Constrained Upside for Outlook Therapeutics
3M ago
OTLK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >